0000899243-20-026282.txt : 20200924 0000899243-20-026282.hdr.sgml : 20200924 20200924160715 ACCESSION NUMBER: 0000899243-20-026282 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200922 FILED AS OF DATE: 20200924 DATE AS OF CHANGE: 20200924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hoffman Steve CENTRAL INDEX KEY: 0001711342 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38169 FILM NUMBER: 201195330 MAIL ADDRESS: STREET 1: 44 WALL STREET STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TYME TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001537917 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 453864597 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 1 PLUCKEMIN WAY - SUITE 103 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 212-461-2315 MAIL ADDRESS: STREET 1: 1 PLUCKEMIN WAY - SUITE 103 CITY: BEDMINSTER STATE: NJ ZIP: 07921 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL GROUP ENTERPRISES CORP. DATE OF NAME CHANGE: 20111221 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-09-22 0 0001537917 TYME TECHNOLOGIES, INC. TYME 0001711342 Hoffman Steve C/O TYME TECHNOLOGIES, INC. 1 PLUCKEMIN WAY, SUITE 103 BEDMINSTER NJ 07921 1 1 1 0 Chief Executive Officer Common Stock 2020-09-22 4 S 0 31250 0.96 D 26043998 D Common Stock 2020-09-23 4 S 0 31250 0.94 D 26012748 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.95 to $0.992 inclusive, on September 22, 2020, and prices ranging from $0.93 to $0.9625, inclusive, on September 23, 2020. The reporting person undertakes to provide to Tyme Technologies, Inc., any security holder of Tyme Technologies, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. By: /s/ Steve Hoffman 2020-09-24